Determinants of human immunodeficiency virus types 1 resistance to gp41- derived inhibitory peptides

Journal of Virology

Volumn 72, Issue 2, 1998, Pages 986-993

  Rimsky, Laurence T ^a   Shugars, Diane C ^a,b   Matthews, Thomas J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SEQUENCE; ANTIVIRAL ACTIVITY; ARTICLE; HUMAN IMMUNODEFICIENCY VIRUS 1; INFECTION RESISTANCE; NONHUMAN; PRIORITY JOURNAL; VIRUS ENVELOPE;

EID: 0031883832     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.2.986-993.1998     Document Type: Article

References (57)

1. Adachi, A., H. E. Gendelman, S. Koenig, T. Folks, R. Willey, A. Rabson, and M. A. Martin. 1986. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59:284-291.
2. Alkhatib, G., C. Combadiere, C. C. Broder, Y. Feng, P. E. Kennedy, P. M. Murphy, and E. A. Berger. 1996. CC CKR5-A Rantes, Mip-1-Alpha, Mip-1-beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272:1955-1958.
3. Barney, S., K. Guthrie, D. E. Davis-Rodhes, R. Medinas, T. Bucy, T. Hauser, J. Erickson, B. DiMassimo, T. Venetta, M. K. Lawless, G. Merutka, and D. M. Lambert. 1996. Synthetic peptides from conserved regions of HIV-1, HIV-2 and SIV fusion proteins are potent antivirals (inhibitors of viral fusion), p. A57, abstr. 134. In 9th International Conference for Antiviral Research.
4. Barney, S., and L. T. Rimsky. Unpublished data.
5. Bates, P. 1996. Chemokine receptors in HIV-1: an attractive pair. Cell 86:1-3.
6. Bernstein, H. B., S. P. Tucker, S. R. Kar, S. A. M. Pherson, D. T. M. Pherson, J. W. Dubay, J. Lebowitch, R. W. Compans, and E. Hunter. 1995. Oligomerization of the hydrophobic heptad repeat on gp41. J. Virol. 69:2745-2750.
7. Black, P. L., O. Wood, D. Broud, M. Bacho, S. Kunder, S. Papermaster, D. Lambert, S. Barney, and M. Ussery. 1996. T-20, a novel inhibitor of HIV-1 fusion, blocks recovery of infectious HIV-1 and inhibits viral load in vivo in the HuPBMC-SKID mouse model, abstr. TU.A.263, p. 221. In XI International Conference on AIDS.
8. Bullough, P. A., F. M. Hughson, J. J. Skehel, and D. C. Wiley. 1994. Structure of the influenza haemagglutinin at the pH of membrane fusion. Nature 371:37-43.
9. Cao, J., L. Bergeron, E. Helseth, M. Thalis, H. Repke, and J. Sodroski. 1993. Effect of amino acid changes in the extracellular domain of the human immunodeficiency virus type 1 gp41 envelope glycoprotein. J. Virol. 67:2747-2755.
10. Carr, C. M., and P. S. Kim. 1993. A spring-loaded mechanism of the conformational change of influenza haemagglutinin. Cell 73:823-832.
11. Chan, D., D. Fass, J. Berger, and P. Kim. 1997. Core structure of gp41 from the HIV envelope glycoprotein. Cell 89:263-273.
12. Chen, C., T. J. Matthews, C. B. McDanal, D. P. Bolognesi, and M. L. Greenberg. 1995. A molecular clasp in the human immunodeficiency virus (HIV) type 1 TM protein determines the anti-HIV activity of gp41 derivatives: implication for viral fusion. J. Virol. 69:3771-3777.
13. Chen, Y., and M. P. Dierich. 1996. Identification of a second site in the HIV-1 gp41 mediating binding to cells. Immunol. Lett. 52:153-156.
14. Choe, H., M. Farzan, Y. Sun, N. Sullivan, B. Rollins, P. D. Ponath, L. Wu, C. R. Mackay, G. L. Rosa, W. Newman, N. Girard, C. Girard, and J. Sodroski. 1996. The chemokine receptors CCR3 and CCR5 facilitate infection by primary isolates. Cell 85:1135-1148.
15. Delwart, E. L., G. Mosialos, and T. Gilmore. 1990. Retroviral envelope glycoproteins contain a leucine zipper-like repeat. AIDS Res. Hum. Retroviruses 6:703-706.
16. Deng, H. K., R. Liu, W. Ellmeier, S. Choe, D. Unutmaz, M. Burkhart, P. Dimarzio, S. Marmon, R. E. Sutton, C. M. Hill, C. B. Davis, S. C. Peiper, T. J. Schall, D. R. Littman, and N. R. Landau. 1996. Identification of a major co-receptor for primary isolates of HIV-1. Nature 381:661-666.
17. Dragic, T., V. Litwin, G. P. Allaway, S. R. Martin, Y. X. Huang, K. A. Nagashima, C. Cayanan, P. J. Maddon, R. A. Koup, J. P. Moore, and W. A. Paxton. 1996. HIV-1 entry into CD4(+) cells is mediated by the chemokine receptor CC-CKR-5. Nature 381:667-673.
18. Feng, Y., C. C. Broder, P. E. Kennedy, and E. A. Berger. 1996. HIV-1 Entry cofactor - functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272:872-877.
19. Freed, E., D. Meyers, and R. Risser. 1990. Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41. Proc. Natl. Acad. Sci. USA 87:4650-4654.
20. Gabuzda, D., U. Olshevsky, P. Bertani, W. A. Haseltine, and J. Sodroski. 1991. Identification of membrane anchorage domains of the HIV-1 gp160 envelope glycoprotein precursor. J. Acquired Immune Defic. Syndr. 4:34-40.
21. Gallaher, W. R. 1987. Detection of a fusion peptide sequence in the transmembrane protein of the human immunodeficiency virus. Cell 80:327-328.
22. Gallaher, W. R., J. M. Ball, R. F. Garry, M. C. Griffin, and R. C. Montelaro. 1989. A general model for the transmembrane proteins of HIV and other retroviruses. AIDS Res. Hum. Retroviruses 5:431-440.
23. Goff, S., P. Traktman, and D. Baltimore. 1981. Isolation and properties of Moloney murine leukemia virus mutants: use of a rapid assay for release of virion reverse transcriptase. J. Virol. 38:239-248.
24. Hart, T. K., R. Kirsh, H. Hellens, R. W. Sweet, D. M. Lambert, S. K. Petteway, J. Leary, and P. Bugelski. 1991. CD4 HIV-1 interactions: binding of soluble CD4 (sT4) to HIV-1 and HIV-1 infected cells induces shedding of envelope gp120. Proc. Natl. Acad. Sci. USA 88:2189-2193.
25. Hopkins, S., and M. Saag. Personal communication.
26. Kowalski, M., L. Bergeron, T. Dorfman, W. Haseltine, and J. Sodroski. 1991. Attenuation of human immunodeficiency virus type 1 cytopathic effect by mutations affecting the transmembrane glycoprotein. J. Virol. 65:281-291.
27. Lambert, D. M., S. Barney, A. L. Lambert, K. Guthrie, R. Medinas, D. E. Davis, T. Bucy, J. Erickson, G. Merutka, and S. R. Petteway. 1996. Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion. Proc. Natl. Acad. Sci. USA 93:2186-2191.
28. Lawless, M. K., S. Barney, K. Guthrie, T. B. Bucy, S. R. Petteway Jr., and G. Merutka. 1996. HIV-1 membrane fusion mechanism: structural studies of the interactions between biologically-active peptides from gp41. Biochemistry 35:13697-13708.
29. Lu, M., S. C. Blacklow, and P. S. Kim. 1995. A trimeric structural domain of the HIV-1 transmembrane glycoprotein. Nat. Struct. Biol. 2:1075-1082.
30. Malim, M. H., J. Hauber, R. Fenrick, and B. R. Cullen. 1988. Immunodeficiency virus rev transactivator modulates the expression of the viral regulatory genes. Nature 331:181-183.
31. Matthews, T. J., C. Wild, C. Chen, D. P. Bolognesi, and M. L. Greenberg. 1994. Structural rearrangement in the transmembrane glycoprotein after receptor binding. Immunol. Rev. 140:93-104.
32. Moore, J. P., R. A. M. Keating, R. A. Weiss, and Q. J. Sattenteau. 1990. Dissociation of gp120 from HIV-1 virions induced by soluble CD4. Science 250:1139.
33. Muster, T., F. Steindl, M. Purtscher, A. Trkola, A. Klima, G. Himmler, F. Rüker, and H. Katinger. 1993. A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1. J. Virol. 67:6642-6647.
34. Myers, G., B. Korber, B. H. Hahn, K. Jeang, J. W. Mellors, F. E. McCutchan, L. E. Henderson, and G. N. Pavlakis. 1995. Human retroviruses and AIDS. Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, N.M.
35. Neurath, A. R., K. Lin, N. Strick, and S. Jiang. 1994. Two partially overlapping antiviral peptides from the external portion of HIV-1 gp41, adjoining the transmembrane region, affect the glycoprotein 41 fusion domain. AIDS Res. Hum. Retroviruses 11:189-190.
36. Neurath, A. R., N. Strick, and S. Jiang. 1992. Synthetic peptides and antipeptide antibodies as probes to study interdomain interactions involved in virus assembly: the envelope of the human immunodeficiency virus (HIV-1). Virology 188:1-13.
37. Rabenstein, M., and Y. K. Shin. 1995. A peptide from the heptad repeat of human immunodeficiency virus gp41 shows both membrane binding and coiled-coil formation. Biochemistry 34:13390-13397.
38. Rabenstein, M. D., and Y. Shin. 1996. HIV-1 gp41 tertiary structure studied by EPR Spectroscopy. Biochemistry 35:13922-13928.
39. Reed, L. J., and H. Muench. 1938. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 27:493-497.
40. Rimsky, L. T., and S. Barney. Unpublished data.
41. Sattentau, Q. J. 1992. CD4 activation of HIV-1 fusion. Int. J. Cell Cloning 10:323-332.
42. Sattentau, Q. J., and J. P. Moore. 1991. Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding. J. Exp. Med. 174:407-415.
43. Shibata, R., M. D. Hoggan, C. Broscius, G. Englund, T. S. Theodore, A. Buckler-White, L. O. Arthur, Z. Israel, A. Schultz, H. C. Lane, and M. A. Martin. 1995. Isolation and characterization of a syncytium-inducing macrophage/T cell line tropic human immunodeficiency virus type 1 isolate that readily infects chimpanzee cells in vitro and in vivo. J. Virol. 69:4453-4462.
44. Shugars, D. C., C. T. Wild, T. K. Greenwell, and T. J. Matthews. 1996. Biophysical characterization of recombinant proteins expressing the leucine zipper-like domain of the human immunodeficiency virus type 1 transmembrane protein gp41. J. Virol. 70:2982-2991.
45. Stern, T. L., M. S. Reitz, and M. Robert-Guroff. 1995. Spontaneous reversion of human immunodeficiency virus type 1 neutralization-resistant variant HXB2thr582: in vitro selection against cytopathicity highlights gp120-gp41 interactive regions. J. Virol. 69:1860-1867.
46. Wain-Hobson, S., P. Sonigo, O. Danos, S. Cole, and M. Alizon. 1985. Nucleotide sequence of the AIDS virus, LAV. Cell 40:9-17.
47. Weissenhorn, W., L. J. Calder, A. Dessen, T. Laue, J. Skehel, and D. C. Wiley. 1997. Assembly of a rod-shaped chimera of a trimeric GCN4 zipper and the HIV-1 gp41 ectodomain expressed in Escherichia coli. Proc. Natl. Acad. Sci. USA 94:6065-6069.
48. Weissenhorn, W., A. Dessen, S. C., Harrisson, J. J. Skehel, and D. C. Wiley. 1997. Atomic structure of the ectodomain from HIV-1 gp41. Nature 387: 426-430.
49. Weissenhorn, W., S. A. Wharton, L. J. Calder, P. L. Earl, B. Moss, E. Aliprandis, J. J. Skehel, and D. C. Wiley. 1996. The ectodomain of HIV-1 env subunit gp41 forms a soluble, alpha-helical, rod-like oligomer in the absence of gp120 and the N-terminal fusion peptide. EMBO J. 15:1507-1514.
50. Wild, C., T. Greenwell, and T. Matthews. 1993. A synthetic peptide from HIV-1 gp41 is a potent inhibitor of virus mediated cell-cell fusion. AIDS Res. Hum. Retroviruses 9:1051-1053.
51. Wild, C., T. Greenwell, D. Shugars, L. Rimsky-Clarke, and T. Matthews. 1995. The inhibitory activity of an HIV type 1 peptide correlates with its ability to interact with a leucine zipper structure. AIDS Res. Hum. Retroviruses 11:323-325.
52. Wild, C., T. Oas, C. McDanal, D. Bolognesi, and T. Matthews. 1992. A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition. Proc. Natl. Acad. Sci. USA 89:10537-10541.
53. Wild, C., D. Shugars, T. Greenwell, C. McDanal, and T. Matthews. 1994. Peptides corresponding to a predictive alpha helical domain of HIV-1gp41 are potent inhibitors of virus infection. Proc. Natl. Acad. Sci. USA 91:9770-9774.
54. Wiley, D. Personal communication.
55. Willey, R. L., D. H. Smith, L. A. Lasky, T. S. Theodore, P. L. Earl, B. Moss, D. J. Capon, and M. A. Martin. 1988. In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity. J. Virol. 62:139-147.
56. Wilson, C., M. S. Reitz, K. Aldrich, P. J. Klasse, J. Bomberg, R. C. Gallo, and M. Robert-Guroff. 1990. The site of an immune-selected point mutation in the transmembrane protein of the human immunodeficiency virus type 1 does not constitute the neutralization epitope. J. Virol. 64:3240-3248.
57. Yu, Y. G., D. S. King, and Y. Shin. 1994. Insertion of a coiled-coil peptide from influenza virus haemagglutinin into membranes. Science 266:274-276.